Home›People›Scott Lippman
Scott Lippman

Scott Lippman

Director at Acurion.

Director
Updated Nov 10, 2026·Latest SEC filing Apr 16, 2026·Suggest an edit

About Scott Lippman

Scott Lippman is a director at Acurion.

Experience

This experience comes from Scott Lippman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Scott Lippman in the role, so the role may have started earlier or lasted longer.

Acurion, Inc. Current
Co-Founder, Board Member, Head of Medical Advisory Board
2022 – Present · San Diego, CA
Acurion develops AI tools that help oncologists identify cancer biomarkers from tissue slides.
UC San Diego Moores Cancer Center Current
Director Emeritus
2012 – Present
UC San Diego School of Medicine Current
Distinguished Professor
2012 – Present
MD Anderson Cancer Center
Adjunct Professor
1988 – 2026
Salk Institute for Biological Studies
Adjunct Professor
2014 – 2024
Sanford Burnham Prebys Graduate School of Biomedical Sciences
Adjunct Professor
2014 – 2023
Harbor-UCLA Medical Center
Internal Medicine Resident
1982 – 1984
Johns Hopkins Hospital
Hospital Residency
1981 – 1982

Key Colleagues at Startups

The people Scott Lippman works with at each company, as listed on that company's latest Form D.

Acurion, Inc. · Form D, Apr 16, 2026
Magda Marquet
Magda Marquet
Board Member, Co-Founder
Webster Cavenee
Webster Cavenee
Board Member, Co-Founder
FF
Frederick Fultz
CEO and director
FF

Sources

  1. SECAcurion, Inc. Form D, filed Apr 16, 2026